ripekg:evaluation/RIPEAA29E3E0362BE3ECB |
prov:used |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAA29E3E0362BE3ECB |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAA29E3E0362BE3ECB |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
ripe:concerns |
ripekg:work/10.1016%2Fj.eururo.2024.10.006Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
ripe:recruitmentEndDate |
03-2017 |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
ripe:recruitmentEndDateExtractionRationale |
Methods: 'Between October 2011 and March 2017, 1432 patients undergoing radical prostatectomy were enrolled at a single center.' so recruitment finish is March 2017 |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
ripe:recruitmentStartDate |
10-2011 |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
ripe:recruitmentStartDateExtractionRationale |
Methods: 'Between October 2011 and March 2017, 1432 patients undergoing radical prostatectomy were enrolled at a single center.' so recruitment start is October 2011 |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
ripe:studyEndDateExtractionRationale |
No explicit study end date found. |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAA29E3E0362BE3ECB-human-2-2 |
ripekg:study-design-evidence/RIPEAA29E3E0362BE3ECB |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAA29E3E0362BE3ECB-inspectai-2-2 |